|
Video: What is a Stock Split?
|
|
Panbela Therapeutics is a clinical stage biopharmaceutical company developing therapeutics for the treatment of patients with cancer. Co.'s product candidate, SBP-101, is a proprietary polyamine analogue designed to induce polyamine metabolic inhibition, a metabolic pathway of critical importance in multiple tumor types. According to our PBLA split history records, PBLA has had 3 splits. | |
|
PBLA (PBLA) has 3 splits in our PBLA split history database. The first split for PBLA took place on January 13, 2023. This was a 1 for 40 reverse split, meaning for each 40 shares of PBLA owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 25 share position following the split. PBLA's second split took place on June 01, 2023. This was a 1 for 30 reverse split, meaning for each 30 shares of PBLA owned pre-split, the shareholder now owned 1 share. For example, a 25 share position pre-split, became a 0.833333333333333 share position following the split. PBLA's third split took place on January 18, 2024. This was a 1 for 20 reverse split, meaning for each 20 shares of PBLA owned pre-split, the shareholder now owned 1 share. For example, a 0.833333333333333 share position pre-split, became a 0.0416666666666667 share position following the split.
When a company such as PBLA conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the PBLA split history from start to finish, an original position size of 1000 shares would have turned into 0.0416666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into PBLA shares, starting with a $10,000 purchase of PBLA, presented on a split-history-adjusted basis factoring in the complete PBLA split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
01/04/2017 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$36,000.00 |
|
End price/share: |
$0.41 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-100.00% |
|
Average Annual Total Return: |
-78.95% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$0.11 |
|
Years: |
7.30 |
|
|
|
Date |
Ratio |
01/13/2023 | 1 for 40 | 06/01/2023 | 1 for 30 | 01/18/2024 | 1 for 20 |
|
|